Svas Biosana S.p.A. (BIT:SVS)
Italy · Delayed Price · Currency is EUR 8.72
+0.22 (2.59%)
At close: Jul 27, 2026
Svas Biosana Revenue
In the year 2025, Svas Biosana had annual revenue of 140.22M EUR with 16.12% growth. Svas Biosana had revenue of 69.64M in the half year ending December 31, 2025, with 6.53% growth.
Revenue (ttm)
141.50M
Revenue Growth
+16.32%
P/S Ratio
0.32
Revenue / Employee
406.77K
Employees
348
Market Cap
45.54M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 140.22M | 19.47M | 16.12% |
| Dec 31, 2024 | 120.75M | -1.59M | -1.30% |
| Dec 31, 2023 | 122.34M | 20.06M | 19.61% |
| Dec 31, 2022 | 102.28M | 20.76M | 25.47% |
| Dec 31, 2021 | 81.52M | 3.81M | 4.91% |
| Dec 31, 2020 | 77.71M | 2.69M | 3.59% |
| Dec 31, 2019 | 75.01M | 4.94M | 7.05% |
| Dec 31, 2018 | 70.07M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.65B |
| Amplifon | 2.39B |
| DiaSorin | 1.17B |
| EL.En. | 595.51M |
| GPI S.p.A. | 546.18M |
| Talea Group | 132.17M |
| Farmacosmo | 56.13M |
| EuKedos | 52.91M |